IDev Technologies, Inc. (IDEV) is an organization focused on innovation, inspiration, and next generation medical device products designed for endovascular interventional use. While the current IDEV patent portfolio contains over thirty technologies exclusively licensed from the M.D. Anderson Cancer Center, the current focus of the company is on the successful commercialization of a novel wire interwoven nitinol (W.I.N.) self-expanding stent. The unique W.I.N. design of the SUPERA®stent will create a new class of self-expanding nitinol stents that provides both unsurpassed strength and flexibility in one stent design.